Explore how proteomics in drug discovery supports drug target identification, biomarker discovery and the unearthing of safer ...

Expert Rev Proteomics. 2009;6(4):421-431. Thus far, many groups have been working in the study of serum protein changes during the development of liver fibrosis. [54–58] It was of great clinical ...

Expression of co-inhibitory receptors or “checkpoint” molecules, such as CTLA-4 and PD-1, on effector T cells is a key mechanism for ensuring immune homeostasis. Dysregulated expression of ...

Data independent analysis and hyper reaction monitoring have recently emerged as new methods of mass spectrometry which address some of the shortcomings of traditional procedures. This review ...

Co announces that it has extended its collaboration agreement with the Medical University of South Carolina. In partnership with Lumera scientists, M.U.S.C researchers intend to develop an antibody ...